In the 2 controlled 12-week research studies, Combivent Inhalation Aerosol did not produce any sort of adjustment in the additional effectiveness specifications including sign ratings, physician international assessments as well as early morning PEFR, each one of which were kept an eye on throughout the research period.
All and any one of those must be stated to your physician prior to the therapy can be begun.